A collection of novel spiroheterocycles with strained aziridine moieties have been facilely synthesized by using easily accessible starting materials under mild reaction conditions. This procedure is robust, scalable and highly diastereoselective, and also features broad substrate scope. In addition, some of the products show promising in vitro biological activity against a spectrum of pathogens, which might be considered as a clue for the discovery of new antimicrobial agents.
Multifunctionalized aziridines, due to their unique and strained core structure, have provoked great interest in both pharmaceutical science and synthetic chemistry. 1 In particular, polycyclic heterocycles containing an aziridine moiety were frequently seen in many bioactive natural products and drug candidates. 2 For example, albomitomycin C, a representative aziridine alkaloid, was isolated from Streptomyces caespitosus culture broth, and can be used as a neoplasm inhibitor (Fig. 1, I) . Antibiotic AX-2 which was derived from mitomycin C 3 shows signicant anticancer activity (Fig. 1, II) . On the other hand, spiropyrrolines have also been demonstrated to be a privileged pharmacophore among various therapeutic chemicals. 4 Merging these two interesting chemical building blocks can lead to a fascinating structural motif named spiro[aziridine-pyrrolines] (SAP), which has been successfully applied in the design of new antimicrobial agents in recent years (e.g. Fig. 1 , III and IV). 5 However, efficient synthesis of such SAP derivatives has not received as much attention as other spirocycles, 6 despite their synthetic usefulness and great potential in medicinal chemistry.
Over the past decades, great efforts have been made to construct aziridines in a rapid and straightforward manner. 7 Signicant advancement has been achieved in this adventure mostly based on three synthetic strategies: intramolecular substitution, direct aziridination of imines and aziridination of alkenes. Notably, it is necessary to pre-install two vicinal functional groups (an amine and a leaving group) in one molecule before using the intramolecular substitution strategy, which requires at least two chemical steps (Scheme 1a). 7a The direct aziridination of imines, on the other hand, provides a variety of generally accepted and well-established methods for manufacturing the desired products; for example, the aza-Corey-Chaykovsky reaction, which involves the addition of sulfur ylides to imines, has been regarded as a robust and powerful protocol in the synthesis of aziridines since the middle of last century (Scheme 1b). 8 Alternatively, the aziridination of alkenes is also a particularly appealing synthetic strategy because of the ready availability of various olenic starting materials; however, such a process is relatively less studied, and the organo-promoted or -catalyzed reactions with this strategy has not been systematically explored until the pioneering work of Loreto, 9a-f Prabhakar 9g,h and Córdova, 9i respectively. Among these studies, there are still a lot of remaining problems 7 in terms of the Fig. 1 Selected natural products and bioactive molecules containing (spiro-)aziridine core structures. 3, 5 reaction efficiency, substrate compatibility and the stereoselectivity (Scheme 1c). Thus, the development of further efficient routes to novel structures of aziridines from easily accessible alkenes is highly desirable.
As part of our continuing interest in constructing medicinal relevant frameworks by using small nonmetal organic molecules, 10 we describe herein a base-promoted highly diastereoselective aziridination of cyclic electron-decient alkenes, which leads to facile synthesis of novel SAP derivatives. Initially, we investigated the feasibility of this approach by evaluating the reaction between readily available enone 1a 10a,b and the modi-ed carbamate 2a. To our delight, the reaction proceeded smoothly in the presence of DABCO in DCM at room temperature, affording the desired product 4a in 52% yield as a single diastereoisomer ( Having established the optimal reaction conditions ( Table 1 , entry 5), we set out to explore the generality of the [2 + 1] cycloadditions. Due to the ketone group that was adjacent to the aziridine moiety, some of the spiro-products were found to be somewhat unstable unless stored under low temperature, which limits the relevant biological study of such frameworks. Thus, a reliable Horner-Wadsworth-Emmons (HWE) reaction was utilized to transform this ketone group to the corresponding a,b-unsaturated ester as the nal bench-stable product 5. As summarized in Table 2 , a variety of cyclic enones 1 bearing either electron-withdrawing ( a Unless otherwise noted, reactions were performed with 0.2 mmol of 1, 0.3 mmol of 2 and 0.3 mmol of DABCO in 2 mL CHCl 3 at rt overnight. The diastereomeric ratio of 4 was determined to be >95 : 5 by 1 H NMR spectroscopy of the crude reaction mixture. The HWE reaction was used for the olenation process, for details, see ESI. b Isolated yield of the aziridination product 4, and the data in parentheses refers to the isolated yield of the olenation product 5. c The structure of 5d was determined by X-ray diffraction analysis, and others were determined by analogy. d Using methyltriphenylphosphonium bromide as the Wittig reagent for the olenation process, see ESI. Bn: benzyl; PMB: pmethoxybenzyl; Boc: t-butyloxy-carboryl; Cbz: carboxybenzyl.
of the phenyl ring reacted efficiently to afford the desired products 5b-5l in excellent diastereoselectivities and nice isolated yields. The reaction was also suitable for enone substrates with polycyclic aromatics, such as 1-naphthyl and 2-naphthyl rings ( Table 2 , entries 13 and 14). It was revealed that the Nprotecting groups of the enones have limited effect on the outcome of this reaction ( Table 2 , entries 15 and 16). On the other hand, in terms of the nucleophile, the Cbz group on the nitrogen atom could also be well tolerated (Table 2, entry 17) . Furthermore, by using Wittig reaction, product 4a could be easily transformed to the corresponding a,b-unsaturated lactam 5r which contains an interesting exocyclic terminal alkenes ( Table 2 , entry 18).
To further illustrate the robustness and practicality of this methodology, the aziridination reaction with 1a was scaled up to 1.0 gram under optimal conditions. Gratifyingly, the desired spiroaziridine 4a and its derivative 5a were smoothly obtained with excellent diastereoselectivity in 88% and 87% yield, respectively (Scheme 2a). It should be worth highlighting that such spiroaziridine skeleton could also be easily transformed to the spiro[lactam-oxazolidinone] core structure; as illustrated in Scheme 2b, in the presence of Cu(OTf) 2 as Lewis acid catalyst, the corresponding product 6 was synthesized in high yield, albeit with moderate diastereoselectivity. Moreover, structural correctness of the spiroaziridines and the relative conguration of the adjacent stereocenters were conrmed by X-ray diffraction analysis of the representative product 5d (Fig. 2 , for details, see ESI †).
In addition, we have demonstrated that the enantioenriched spiroaziridine 5a could be synthesized by using the readily available and relatively inexpensive quinidine as the chiral Brønsted base (Scheme 3). However, considering its moderate enantioselectivity and high loading of the chiral base, further optimization is still in urgent demand and currently underway in our lab.
The collection of new compounds 5a-5r was screened for in vitro antibacterial activity against Staphylococcus aureus (ATCC 25923), methicillin-resistant Staphylococcus aureus (MRSA, clinic isolates) and Proteus mirabilis (clinic isolates). 12 It was revealed that some of these spiroaziridines exhibited promising bioactivity, with the minimum inhibitory concentrations (MICs) value ranging from 8 to 128 mg mL À1 . Particularly, compound 5c Scheme 2 Gram-scale synthesis of spiroaziridines 4a and 5a, and the synthetic transformation of 5a. Fig. 2 Single crystal X-ray diffraction analysis of product 5d. 11 Scheme 3 Asymmetric synthesis of chiral spiroaziridine 5a by using commercially available quinidine. shows obvious in vitro antibacterial activity against MRSA which is regarded as a clinically important pathogen (Table 3) .
Conclusions
In summary, we have successfully developed a highly diastereoselective aziridination reaction of cyclic enones under mild condition, giving an efficient access to a class of novel spiroaziridines. This approach is highly practical and functional group tolerant, which allows for large-scale synthesis and rapid assembly of substituent divergent products from simple, readily available starting materials. Preliminary biological studies of the synthesized compounds showed promising in vitro antibacterial activity against S. aureus, MRSA and P. mirabilis. Asymmetric organocatalysis of this aziridination process and further medicinal chemistry studies upon these novel structures are our current research interests, and the result will be reported in due course.
